Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Konrad Kronenberger"'
Autor:
Elfriede Nöner, Ralph Mocikat, Martin Dreyling, Bernhard Frankenberger, Ulrich Wahl, Michael Hallek, Konrad Kronenberger
Publikováno v:
Journal of Immunotherapy. 31:723-730
B cell-derived chronic lymphocytic leukemia (CLL) is an incurable disease that requires innovative therapeutic regimens. Experimental approaches of immunotherapy aiming at induction of systemic T-cell responses have been developed. Trioma cells provi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8244cc4e6b0d30370a797dad6cf7e404
https://doi.org/10.1097/cji.0b013e318183af26
https://doi.org/10.1097/cji.0b013e318183af26
Autor:
Martin Röcken, Elfriede Nößner, Carolin Lüking, Konrad Kronenberger, Ralph Mocikat, Bernhard Frankenberger
Publikováno v:
International Journal of Cancer. 122:2280-2285
Tumor-specific T cells are crucial for immunologic control of malignant disease. T cells can be induced in vivo by vaccination or adoptively transferred after activation ex vivo. We investigated the requirements for generating T cells with optimal an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ca19dc82e53e38bfec08d75f01333c4
https://doi.org/10.1002/ijc.23393
https://doi.org/10.1002/ijc.23393
Autor:
Elfriede Nössner, Michael Hallek, Ralph Mocikat, Thomas Allgeier, Martin Dreyling, Ulrich Wahl, Konrad Kronenberger, Silke Garhammer
Publikováno v:
Cancer letters. 245(1-2)
Hybrids generated from tumor cells and dendritic cells (DC) have been proposed as tools for treating malignant disease. Here, we study the underlying principles and the feasibility for the adjuvant therapy of human B cell chronic-lymphocytic leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86c763fa4b0a1825f26c8b456e799720
https://pubmed.ncbi.nlm.nih.gov/16516377
https://pubmed.ncbi.nlm.nih.gov/16516377
Autor:
Ulrich, Wahl, Elfriede, Nössner, Konrad, Kronenberger, Rainer, Gangnus, Heike, Pohla, Martin S, Staege, Hans-Jochem, Kolb, Michael, Hallek, Ralph, Mocikat
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(11)
Trioma cells are lymphoma cells that have been fused to a hybridoma and have thereby been modified to express an immunoglobulin directed against surface receptors of antigen-presenting cells. Trioma cells that potentially include all lymphoma-derived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e6fdaf3ba0c542c6578bd347793b758
https://pubmed.ncbi.nlm.nih.gov/14519651
https://pubmed.ncbi.nlm.nih.gov/14519651
Autor:
Ralph Mocikat, John Strehl, Ulrich Wahl, Andreas Dieckmann, Michael Selmayr, Georg Kraal, Konrad Kronenberger, Horst Lindhofer
Publikováno v:
Blood 99, 1327-1331 (2002)
Trioma cell vaccination is a potent new immunologic approach for the therapy of malignant B-cell lymphoma. It is based on targeting tumor antigens to internalizing receptors on antigen-presenting cells (APCs). Tumor cells are fused to an APC-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0870e32efb88c3267d94b37f74d824b
https://pubmed.ncbi.nlm.nih.gov/11830483
https://pubmed.ncbi.nlm.nih.gov/11830483
Publikováno v:
The Journal of Immunology. 178:S140-S140
While Fibroblastic Reticulum Cells (FRC) of the lymph node (LN) are known to produce chemokines responsible for the migration of naïve T cells and DC, little is known about their interactions with these cells and their influence on DC and T cell ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd92d996c3d88392d4c2670056291eb7
https://doi.org/10.4049/jimmunol.178.supp.88.10
https://doi.org/10.4049/jimmunol.178.supp.88.10